Skip to content

Public FDA record

Z-2160-2024: NxStage PureFlow-B Solution, Premixed Dialysate for Hemodialysis, Device Catalog Numbers RFP-400, RFP-401

Recall record Z-2160-2024 for NxStage Medical Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2160-2024
Company in FDA record
NxStage Medical Inc
FDA classification date
Jun 20, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The smaller chamber of the two chamber bag is bursting when nurses are attempting to mix the two chambers prior to use. The electrolyte fluid in the small chamber of the NxStage PureFlow B Solution has a pH of less than 2.0. The solution can be harmful if it comes in contact with the eyes or skin, and/or as a result of a slip or fall injury due to spilled fluid.

Source facts

Action
An URGENT MEDICAL DEVICE RECALL dated 5/14/24 was sent to customers. Action to be taken by Customers 1. Check all boxes in your Pureflow B solution inventory. If you find any boxes or individual bags of Pureflow B solution from the affected lots, separate them from your other inventory and do not use them. (Refer to Appendix B for how to locate lot number). 2. Follow the instructions on the attached reply form to acknowledge your receipt of this notice. 3. Contact NxStage Customer Service (acuteorders@freseniusmedicalcare.com) to arrange for the return of all affected product. We understand that dialysis fluids are critical to patient care, and immediately removing these fluids from your facility may result in the inability to treat critically ill patients. If no alternatives are available, use of PPE (goggles) and activation of bags away from patients and other personnel will limit possibility of injury due to exposure to the fluid from the small chamber. Action to be taken by NxStage NxStage is sending this notice to all facilities that have received affected RFP-4XX to alert you of the issue and request return of the Product. As a result of this action, we expect a temporary shortage of some low volume formulations for approximately 2 weeks. NxStage is working diligently to ensure expedited product availability by securing additional supply via multiple channels If you have any questions or comments, please contact NxStage Customer Service at 1-866-NXSTAGE (1-866-697-8243).
Initiated
2024-05-14
Root cause
Under Investigation by firm
Distribution
US Nationwide distribution.
Recall number
Z-2160-2024
Recall status
Open, Classified
CDRH record ID
207915
FDA classified
2024-06-20
Recall event number
94641

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗